Benjamin Edwards Inc. Boosts Stock Holdings in CorVel Corp. (NASDAQ:CRVL)

Benjamin Edwards Inc. grew its position in shares of CorVel Corp. (NASDAQ:CRVL) by 20.4% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,383 shares of the business services provider’s stock after acquiring an additional 403 shares during the quarter. Benjamin Edwards Inc.’s holdings in CorVel were worth $267,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also recently bought and sold shares of the company. Xponance Inc. raised its stake in shares of CorVel by 4.9% during the 1st quarter. Xponance Inc. now owns 2,008 shares of the business services provider’s stock worth $225,000 after purchasing an additional 94 shares during the period. Ballentine Partners LLC raised its stake in shares of CorVel by 4.2% during the 1st quarter. Ballentine Partners LLC now owns 2,531 shares of the business services provider’s stock worth $283,000 after purchasing an additional 102 shares during the period. Mayfair Advisory Group LLC raised its stake in shares of CorVel by 7.2% during the 1st quarter. Mayfair Advisory Group LLC now owns 2,212 shares of the business services provider’s stock worth $248,000 after purchasing an additional 148 shares during the period. LGT Financial Advisors LLC raised its stake in shares of CorVel by 200.0% during the 4th quarter. LGT Financial Advisors LLC now owns 255 shares of the business services provider’s stock worth $28,000 after purchasing an additional 170 shares during the period. Finally, Meeder Asset Management Inc. bought a new stake in shares of CorVel during the 1st quarter worth $25,000. 51.36% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In related news, EVP Mark E. Bertels sold 900 shares of the business’s stock in a transaction dated Tuesday, May 27th. The stock was sold at an average price of $113.34, for a total value of $102,006.00. Following the sale, the executive vice president directly owned 2,586 shares in the company, valued at approximately $293,097.24. The trade was a 25.82% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Maxim Shishin sold 2,400 shares of the business’s stock in a transaction dated Monday, June 9th. The shares were sold at an average price of $108.09, for a total value of $259,416.00. Following the completion of the sale, the insider owned 7,050 shares in the company, valued at $762,034.50. This represents a 25.40% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 13,079 shares of company stock worth $1,446,023 in the last ninety days. 44.56% of the stock is owned by corporate insiders.

CorVel Price Performance

NASDAQ CRVL opened at $88.22 on Friday. The stock has a market capitalization of $4.53 billion, a price-to-earnings ratio of 45.47 and a beta of 0.95. CorVel Corp. has a one year low of $85.13 and a one year high of $128.61. The business’s fifty day moving average is $96.75 and its 200-day moving average is $106.76.

CorVel (NASDAQ:CRVL) last released its earnings results on Tuesday, August 5th. The business services provider reported $0.52 EPS for the quarter. CorVel had a return on equity of 32.31% and a net margin of 10.98%.

CorVel Profile

CorVel Corporation provides workers’ compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.